90 reports

  • IV. MONOCLONAL ANTIBODY PRODUCTION AND
  • Monoclonal Antibody Markets in China

Autoimmunity Diseases Treatment Antibody is one important Monoclonal Antibody in China.

  • Monoclonal Antibody
  • China
  • Demand
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

EXECUTIVE SUMMARY ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • APAC
  • Demand
  • Monoclonal Antibody Companies in China
  • Monoclonal Antibody Sales Volume

Autoimmunity Diseases Treatment Antibody is one important Monoclonal Antibody in China.

  • Monoclonal Antibody
  • China
  • Demand
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Roche Group
  • Demand of Monoclonal Antibody by Region
  • Monoclonal Antibody Sales Volume

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Monoclonal Antibody in China is growing rapidly.

  • Monoclonal Antibody
  • Targeted Therapy
  • China
  • Demand
  • Beijing Biotech Pharmaceutical Co., Ltd.

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in monoclonal antibody dealmaking ##. ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • Demand

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials Executive Summary Chapter ## – Introduction Chapter ## – Trends in Cancer monoclonal antibody dealmaking ##. ##.

  • Cancer
  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Demand

The 2020-2025 World Outlook for Monoclonal Antibody (MAb)-Based Products ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Biosimilar Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

The Development of Therapeutic Monoclonal Antibody Products CHAPTER ##: The Therapeutic Monoclonal Antibody Market ## CHAPTER ##: Overview of Chemistry, Manufacturing, and Control Activities for Monoclonal Antibody Product Developm

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Demand

Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024 Table of Contents Chapter

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • United States
  • Demand
  • Monoclonal Antibody
  • IV. BIOLOGICS SALES VOLUMES AND FORECASTS

In 2008, monoclonal antibody sales were only ##. ## billion Yuan.

  • Monoclonal Antibody
  • China
  • Demand
  • Dongguan Winnerway Bio-Tech Co., Ltd.
  • Shenzhen Main Luck Pharmaceuticals Inc.

UNLIKE THE GENERICS OF SMALL MOLECULES, WHICH ARE OFTEN PRICED AT A SUBSTANTIAL DISCOUNT TO THE ORIGINATOR BRAND, BIOSIMILARS OF THE MONOCLONAL ANTIBODY (MAB) THERAPIES FOR PLAQUE PSORIASIS ARE PRICED ONLY MARGINALLY LOWER THAN THE CORRESPONDING BIOLOGIC BRAND.

  • Monoclonal Antibody
  • Demand
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

CANADIAN KEY OPINION LEADER MOST OF THE CURRENT PHASE III REGISTRATIONAL TRIALS THAT ARE INVESTIGATING COMBINATION THERAPIES INVOLVE AT LEAST ONE ANTI-CD## MONOCLONAL ANTIBODY.

  • Monoclonal Antibody
  • Demand
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Roche Group
  • Competitive Assessment of the Late-Stage Pipeline Agents that GlobalData Expects to be

ELI LILLY' S MIRIKIZIMAB IS A HUMANIZED MONOCLONAL ANTIBODY THAT SELECTIVELY BINDS TO THE P## SUBUNIT UNIQUE TO CYTOKINE IL-##, NEUTRALIZING ITS ACTIVITY.

  • Monoclonal Antibody
  • Demand
  • AbbVie Inc.
  • Pfizer Inc.
  • Remicade group

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Europe
  • Demand
  • Forecast
  • MONOCLONAL ANTIBODIES IN CANCER TREATMENT, OPDIVO PERFORMANCE VS. INDUSTRY, 2010-2022
  • MONOCLONAL ANTIBODIES AND BACE INHIBITORS WILL DRIVE ALZHEIMER'S DISEASE TREATMENT GROWTH, 2016-2022 ($ MILLIONS)

FIGURE ##-##: MONOCLONAL ANTIBODIES IN CANCER TREATMENT, OPDIVO PERFORMANCE VS.

  • Monoclonal Antibody
  • Demand
  • AstraZeneca PLC
  • Novartis AG
  • Pfizer Inc.

Approaches Used in Development of TNF Inhibitors ##. ## Monoclonal Antibody Approach ##. ## Recombinant DNA Technology Approach ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World
  • Demand

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Demand

IT IS GUT-SELECTIVE MONOCLONAL ANTIBODY AND HAS SUPERIOR SAFETY PROFILE COMPARED TO ANTI-TNFS.

  • Monoclonal Antibody
  • Demand
  • EA Pharma Co., Ltd.
  • Pfizer Inc.
  • Remicade group

The report also examines market applications of DNA probes, biochips/ microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent

  • Diagnostics
  • In Vitro Diagnostics
  • Monoclonal Antibody
  • Therapy
  • Demand

The report also examines market applications of DNA probes, biochips/ microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent

  • Diagnostics
  • In Vitro Diagnostics
  • Monoclonal Antibody
  • Therapy
  • Demand
  • Monoclonal antibody
  • Gilead Sciences,Inc

Monoclonal antibody ENDPOINT RESULTS FOR DRUGS IN CHRONIC LYMPHOCYTIC LEUKAEMIA EXHIBIT ##: EFFICACY RESULTS FROM STUDY ## IN RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA (##) DRUG: ZYDELIG/ IDELALISIB PFS: progression-free survival; NR: not reached The p value for PF

  • Leukemia
  • Monoclonal Antibody
  • United States
  • Demand
  • Gilead Sciences, Inc.

KEYTRUDA, A HUMANIZED ANTI-PD-## MONOCLONAL ANTIBODY, BINDS TO PD-## RECEPTORS AND BLOCKS THEM FROM THE INHIBITORY EFFECT OF PD-## LIGANDS, PROMOTING A T-CELL RESPONSE.

  • Monoclonal Antibody
  • Demand
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Italy
  • Demand
  • Forecast
  • Imatinib Mesylate Major Producer and Their Market
  • Share (million Yuan)

Chart ##: Imatinib Mesylate Sales Volume and Market Share (million Yuan) Rituximab Table ##: Imatinib Mesylate Major Producer and Their Market Share (million Yuan) Rituximab is a chimeric monoclonal antibody against the protein CD##.

  • Monoclonal Antibody
  • China
  • Demand
  • Lijun Pharmaceutical Co., Ltd.
  • Shanghai Schering-Plough Pharmaceutical Company, Ltd